Standard BioTools grants 500,000 RSUs to Chief Business Officer Sean Mackay

Filed June 3, 2026 · Period ending May 29, 2026 · ~1 min read

Key Changes

• medium

  Chief Business Officer Sean Mackay received 500,000 restricted stock units under the 2026 Equity Incentive Plan, effective June 20, 2026. The grant vests 40% in 2027 and 60% in 2028, contingent on continued service.

  Item 5.02 verify on EDGAR →
• medium

  The two-tranche vesting schedule (200,000 units in year one, 300,000 in year two) creates retention incentives for a key commercial executive through mid-2028.

  8-K: Executive Compensation verify on EDGAR →